These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32869831)

  • 1. Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
    Bezzio C; Pellegrini L; Manes G; Arena I; Picascia D; Della Corte C; Devani M; Schettino M; Saibeni S
    Inflamm Bowel Dis; 2020 Sep; 26(10):e107-e109. PubMed ID: 32869831
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory Bowel Disease Management in a Major Referral Center During COVID-19 Pandemic.
    Garrido I; Lopes S; Macedo G
    Inflamm Bowel Dis; 2020 Sep; 26(10):e114-e115. PubMed ID: 32737966
    [No Abstract]   [Full Text] [Related]  

  • 3. Low frequency of COVID-19 in inflammatory bowel diseases.
    Marafini I; Salvatori S; Sena G; Calabrese E; Biancone L; Monteleone G
    Dig Liver Dis; 2020 Nov; 52(11):1234-1235. PubMed ID: 32601036
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre.
    Zingone F; Buda A; Savarino E
    Dig Liver Dis; 2020 Nov; 52(11):1248-1249. PubMed ID: 32811778
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns.
    Festa S; Aratari A; De Biasio F; Fascì-Spurio F; Papi C
    Dig Liver Dis; 2020 Nov; 52(11):1246-1247. PubMed ID: 32527654
    [No Abstract]   [Full Text] [Related]  

  • 6. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak.
    Zingone F; Savarino EV
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):525. PubMed ID: 32220656
    [No Abstract]   [Full Text] [Related]  

  • 7. IBD in the Times of COVID-19.
    Hernández Benabe S; Langshaw AH
    Inflamm Bowel Dis; 2020 Jul; 26(8):e92. PubMed ID: 32448895
    [No Abstract]   [Full Text] [Related]  

  • 8. Concerns related to COVID-19 pandemic among patients with inflammatory bowel disease and its influence on patient management.
    Bodini G; Demarzo MG; Casagrande E; De Maria C; Kayali S; Ziola S; Giannini EG
    Eur J Clin Invest; 2020 May; 50(5):e13233. PubMed ID: 32294238
    [No Abstract]   [Full Text] [Related]  

  • 9. Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
    Prentice RE; Al-Ani AH; Bond K; Johnson D; Christensen B
    Dig Liver Dis; 2020 Nov; 52(11):1250-1251. PubMed ID: 32928674
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study.
    Singh S; Khan A; Chowdhry M; Bilal M; Kochhar GS; Clarke K
    Gastroenterology; 2020 Oct; 159(4):1575-1578.e4. PubMed ID: 32522507
    [No Abstract]   [Full Text] [Related]  

  • 11. Excessive anxiety in IBD patients is unnecessary for COVID-19.
    Wang HG; Xie R; Ma TH; Yang XZ
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):e121-e122. PubMed ID: 32409282
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic.
    Martinelli M; Strisciuglio C; Fedele F; Miele E; Staiano A
    Inflamm Bowel Dis; 2020 Aug; 26(9):e95-e96. PubMed ID: 32440675
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever.
    Benson-Pope SJ; Gearry RB
    Aliment Pharmacol Ther; 2020 Aug; 52(4):717-718. PubMed ID: 32886355
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 vaccinations in patients with inflammatory bowel disease.
    Kumar A; Quraishi MN; Segal JP; Raine T; Brookes MJ
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):965-966. PubMed ID: 32971020
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.
    Burgueño JF; Abreu MT
    Inflamm Bowel Dis; 2020 Sep; 26(10):e127. PubMed ID: 32619011
    [No Abstract]   [Full Text] [Related]  

  • 16. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.
    Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B
    Intern Med J; 2020 Jul; 50(7):798-804. PubMed ID: 32656985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opening Up Resident Education During the Coronavirus Disease (COVID-19) Pandemic and Beyond.
    Bassuner J; Rindy L; Tew D; Vatakencherry G
    AJR Am J Roentgenol; 2020 Oct; 215(4):W48. PubMed ID: 32755189
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic inflammatory bowel disease and COVID-19].
    Moum B
    Tidsskr Nor Laegeforen; 2020 May; 140(7):. PubMed ID: 32378846
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the Editor: Coronavirus Disease 2019 (COVID-19): A New York City Intern's Perspective.
    Schupper AJ
    World Neurosurg; 2020 Aug; 140():489-490. PubMed ID: 32535053
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-CoV-2 From the Trenches: A Perspective From New York City.
    Gozansky EK; Moore WH
    AJR Am J Roentgenol; 2020 Jul; 215(1):27-28. PubMed ID: 32301630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.